vix.ing · top · new · best · stats

The Application of Treatment Guidelines in Multiple Sclerosis Care: A Qualitative Analysis of Barriers and Facilitators

2026/01/02 by Isabelle Weld-Blundell, Yvonne C. Learmonth, Marlena Klaic +6 · 1 voice
Health Professions · Medicine · #Clinical practice guidelines implementation #Mental Health and Patient Involvement #Multiple Sclerosis Research Studies

paper · doi:10.7224/1537-2073.2025-048

openalex created_date 2026/01/02 · openalex publication_date 2026/01/02 · openalex updated_date 2026/07/18

Abstract

Background: To improve the quality and standard of care, considerable resources are invested to produce clinical guidelines for multiple sclerosis (MS) management. We aimed to investigate MS clinicians’ use of guidelines and factors that influence use. Methods: Interview guides were developed using Fisher’s framework to assess factors that influence guideline application (categorized as personal, guideline related, and external). Nurses and neurologists experienced in MS health care were recruited through convenience sampling. Semistructured online interviews were conducted from June 2023 to October 2023, and data were analyzed using inductive and deductive methods. Results: We interviewed 16 MS clinicians (10 nurses, 6 neurologists). Despite most clinicians believing that guidelines can improve consistency, safety, and quality of care, the application of guidelines was highly variable. Participants reported that clinical decision-making in MS management involves integrating guideline recommendations with clinical reasoning while considering patients’ circumstances and preferences, the complex nature of MS, and resource constraints. Personal barriers to guideline application included low awareness and familiarity. Guideline-related barriers included evidence, plausibility, accessibility, layout, and complexity. External barriers included a lack of resources. Facilitators were mostly guideline related, including relevance to local protocols, covering complex treatment or unfamiliar topics, and when guidelines were up to date and credible. Participants suggested various strategies to overcome barriers to guideline use. Conclusions: Australian MS clinicians reported low awareness and high variability in the application of national and/or international MS guidelines. Clinical practice guidelines should be adaptable to local contexts, accessible, and regularly updated. Multifaceted strategies to better distribute and champion guidelines should be employed.

Discussions

Related